Stay updated on Atrasentan in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the Atrasentan in IgA Nephropathy Clinical Trial page.

Latest updates to the Atrasentan in IgA Nephropathy Clinical Trial page
- Check3 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record content with an access-denied notice. The header/navigation remains visible, indicating restricted access to the page.SummaryDifference19%

- Check10 days agoChange DetectedThe page now displays revision v3.7.0, replacing the previous v3.6.6 tag. This indicates a metadata/version update rather than a change to study information.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6. This represents a new release of the page content, typically including small edits or fixes.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page footer now displays Revision: v3.6.5, replacing the previous v3.6.4. This reflects a software version update rather than a modification to the study details.SummaryDifference0.0%

- Check59 days agoChange DetectedA new bibliographic reference for the Endothelin System in Hypertension and CKD was added to Publications/References, and the page revision was updated to v3.6.4 (replacing v3.6.3).SummaryDifference0.0%

- Check73 days agoChange DetectedAdded the final Lancet publication citation for the ALIGN IgA nephropathy results and removed the earlier online-ahead-of-print Lancet citation, updating the Publications section to reflect the final article.SummaryDifference0.0%

Stay in the know with updates to Atrasentan in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atrasentan in IgA Nephropathy Clinical Trial page.